PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

283 Datensätze gefunden.
Export: RSS RSS Feed
Vergeben Sie einen Titel für den Feed:
RSS Excel (CSV) TXT Text RIS Endnote (RIS) BIB BibTeX Word Word (RTF)
Überschrift:
Unterüberschrift:
Datum:
Autorenliste:
Impact Factor ausgeben:
DOI ausgeben:
embedHTML/TYPO3
Alle Publikationen dieser Seite in den Korb legen
61.
Bovy, N.* et al.: Long-term follow-up study of type 1 diabetes patients previously treated with IMCY-0098 or placebo in young adults with recent-onset type 1 diabetes. Diabetologia 63, 1, S26-S27 (2020)
62.
Brings, S.* ; Fleming, T.* ; Herzig, S. ; Nawroth, P.P.* & Kopf, S.*: Urinary cathepsin levels are predictive of the improvement of albuminuria and are associated with elevated excretion of free glucosepane. Diabetologia 63, 1, S384-S385 (2020)
63.
Cobo-Vuilleumier, N.* et al.: Lrh1/nr5a2 conveys the anti-diabetic effects of the agonist bl001 and promotes alpha-to-beta-cell conversion in streptozotocin-treated mice. Diabetologia 63, 1, S182-S183 (2020)
64.
De Luca, C.* et al.: Factors affecting function of human pancreatic islets after isolation. Diabetologia 63, 1, S179-S179 (2020)
65.
Gallegos, P.A. et al.: Presence of markers associated with viral infections in the pancreas before and after onset of type 1 diabetes. Diabetologia 63, 1, S157-S157 (2020)
66.
Ghalwash, M.* et al.: Optimal ages for screening for type 1 diabetes risk in children. Diabetologia 63, 1, S181-S181 (2020)
67.
Hummel, J. et al.: Brain insulin sensitivity is modulated by menstrual cycle. Diabetologia 63, 1, S14-S14 (2020)
68.
Jall, S. et al.: Pharmacological targeting of α3β4 nicotinic receptors improves peripheral insulin sensitivity in mice with diet-induced obesity. Diabetologia 63, 1236-1247 (2020)
69.
Khamis, A.* et al.: Pnliprp1 hypermethylation in human exocrine pancreas reveals a link between diabetes and pancreatic cancer. Diabetologia 63, 1, S109-S109 (2020)
70.
Koivula, R.W.* et al.: The role of physical activity in metabolic homeostasis before and after the onset of type 2 diabetes: An IMI DIRECT study. Diabetologia 63, 744-756 (2020)
71.
Koivula, R.W.* et al.: Correction to: The role of physical activity in metabolic homeostasis before and after the onset of type 2 diabetes: an IMI DIRECT study (Diabetologia, (2020), 63, 4, (744-756), 10.1007/s00125-019-05083-6). Diabetologia 64, 260-261 (2020)
72.
Kullmann, S. et al.: Empagliflozin improves insulin sensitivity of the hypothalamus in humans with prediabetes. Diabetologia 63, 1, S13-S14 (2020)
73.
Kwon, B.* et al.: A visual analytics method to explore the evolution of autoantibodies during progression to type 1 diabetes in multi-site birth cohort studies. Diabetologia 63, 1, S159-S159 (2020)
74.
Lamprinou, A.* et al.: Evaluation of determinants of hepatic insulin clearance: a Mendelian randomisation study. Diabetologia 63, 1, S36-S37 (2020)
75.
Marinicova, Z. et al.: Presentation of insulin granule derived peptides on MHC I in Enterovirus-infected beta cells and type 1 diabetes. Diabetologia 63, 1, S111-S111 (2020)
76.
Mattila, M.* et al.: Plasma ascorbic acid and the risk of islet autoimmunity and type 1 diabetes: The TEDDY study. Diabetologia 63, 278-286 (2020)
77.
Oquendo, M.B. et al.: Comparison between in vitro differentiation of pancreatic and subcutaneous adipocytes of subjects with normal glucose tolerance. Diabetologia 63, 1, S254-S255 (2020)
78.
Scarale, M.* et al.: Circulating metabolites significantly improve the prediction of renal dysfunction in type 2 diabetes. Diabetologia 63, 1, S3-S3 (2020)
79.
Scarale, M.* et al.: Building clinical risk score systems for predicting all-cause and cardiovascular-specific mortality among type 2 diabetes patients. Diabetologia 63, S3-S4 (2020)
80.
Suleiman, M.* et al.: Glucose-lowering therapy and ex-vivo beta cell function in type 2 diabetes. Diabetologia 63, 1, S196-S196 (2020)